Experts discuss the emerging role of SERDs in HR+ breast cancer
touchPANEL DISCUSSION for touchONCOLOGY
Listen to leading experts review the latest advances in HR+ breast cancer, focusing on the management of specific patient subgroups and the potential impact of emerging oral, second-generation SERDs on patient standard of care.
The experts
Prof. Hope S Rugo – UCSF Comprehensive Cancer Center, San Francisco, CA, USA
Dr Fatima Cardoso – Champalimaud Clinical Center, Lisbon, Portugal
Dr Matti Aapro – Genolier Cancer Center, Genolier, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.